Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Gains from Investment Securities (2016 - 2026)

Anika Therapeutics has reported Gains from Investment Securities over the past 16 years, most recently at $1.7 million for Q1 2026.

  • Quarterly Gains from Investment Securities rose 1741.11% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.7 million through Mar 2026, up 7342.22% year-over-year, with the annual reading at $1.8 million for FY2025, 15.51% down from the prior year.
  • Gains from Investment Securities was $1.7 million for Q1 2026 at Anika Therapeutics, up from $1.3 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $2.3 million in Q1 2024 and troughed at -$284000.0 in Q4 2022.
  • The 5-year median for Gains from Investment Securities is $16300.0 (2025), against an average of $413547.1.
  • Year-over-year, Gains from Investment Securities tumbled 550.79% in 2022 and then skyrocketed 21100.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at -$284000.0 in 2022, then soared by 97.54% to -$7000.0 in 2023, then skyrocketed by 21100.0% to $1.5 million in 2024, then dropped by 13.27% to $1.3 million in 2025, then grew by 29.96% to $1.7 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Gains from Investment Securities are $1.7 million (Q1 2026), $1.3 million (Q4 2025), and $2000.0 (Q3 2025).